Tag: RayzeBio
Bristol Myers: success of the takeover bid for RayzeBio
(CercleFinance.com) – Bristol Myers Squibb announces the success of its takeover bid (OPA) for RayzeBio shares, for a purchase price of $62.50 per share, or approximately $4.1 billion, Takeover bid…
Bristol Myers: Expiration of the HSR period for RayzeBio
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…